Pharmacological and Cellular Therapies to Prevent Restenosis after Percutaneous Transluminal Angioplasty and Stenting

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 6, Iss. 2, 2008-01 ,pp. : 116-124

Bentham Science Publishers

Access to resources Recommend Favorite

C-reactive protein and coronary events following percutaneous coronary angioplasty

By de Winter R.J.   Koch K.T.   van Straalen J.P.  

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 49-50

Elsevier

Access to resources Recommend Favorite

Appropriateness of Percutaneous Transluminal Coronary Angioplasty in Stable and Unstable Angina Pectoris. A review

By Grip Lars  

Scandinavian Cardiovascular Journal, Vol. 34, Iss. 5, 2000-11 ,pp. : 454-460

Informa Healthcare

Access to resources Recommend Favorite

Intravascular ultrasound imaging of myocardial-infarction-related arteries after percutaneous transluminal coronary angioplasty reveals significant plaque burden and compensatory enlargement

By Frimerman Aaron   Miller Hylton I   Siegel Robert J   Rosenschein Uri   Roth Arie   Keren Gad  

International Journal of Cardiovascular Interventions, Vol. 2, Iss. 2, 1999-01 ,pp. : 101-107

Informa Healthcare

Access to resources Recommend Favorite

Microemboli at the Different Stages of Percutaneous Transluminal Carotid Angioplasty and Stenting in Patients with Post–carotid Endarterectomy Restenosis Compared to Primary Stenosis

By Telman Gregory  

International Journal of Angiology, Vol. 13, Iss. 1, 2004-02 ,pp. : 37-41

Springer Publishing Company

Access to resources Recommend Favorite